Why is Biogen Pharma falling/rising?

As of 24-Sep, Biogen Pharmachem Industries Ltd is currently priced at 0.89, showing no change (0.00%). The stock has been trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward trend. Over the past week, the stock has decreased by 1.11%, while it has experienced a more significant decline of 24.58% year-to-date. However, there has been a rise in investor participation, with delivery volume increasing by 27.25% against the 5-day average, suggesting some interest despite the overall negative performance. There are no positive or negative factors explicitly mentioned that could further clarify the stock's recent movement.
Broader market context shows that Biogen Pharma's performance has been relatively weak compared to the benchmark Sensex. While the Sensex has gained 0.50% over the past month, Biogen Pharma has declined by 2.20% in the same period. Year-to-date, the stark contrast continues with Biogen's 24.58% drop against the Sensex's 4.58% increase. This underperformance highlights the challenges faced by Biogen Pharma in the current market environment, despite a slight uptick in trading activity.